Kim Robert Young
Insider CIK 1971608 · FDMT Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2025-03-06 | 2025-03-10 | 92,300 | — | $0 | 92,300 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-02-05 | 2024-02-07 | 6,000 | — | $0 | 64,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-02-05 | 2024-02-07 | 12,000 | — | $0 | 138,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-02-05 | 2024-02-07 | 6,000 | — | $0 | 54,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-02-05 | 2024-02-07 | 6,000 | $30.05 | $180.3K | 1,595 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-02-05 | 2024-02-07 | 6,000 | $30.05 | $180.3K | 1,595 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-02-05 | 2024-02-07 | 6,000 | $8.04 | $48.2K | 7,595 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-02-05 | 2024-02-07 | 552 | $30.05 | $16.6K | 1,043 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-02-05 | 2024-02-07 | 6,000 | $15.78 | $94.7K | 7,595 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-02-05 | 2024-02-07 | 12,000 | $30.05 | $360.6K | 1,595 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-02-05 | 2024-02-07 | 12,000 | $18.66 | $223.9K | 13,595 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2023-12-11 | 2023-12-13 | 250,000 | — | $0 | 250,000 | SEC↗ |